Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

ProPhase Labs (PRPH) EBT Margin: 2010-2025

Historic EBT Margin for ProPhase Labs (PRPH) over the last 16 years, with Sep 2025 value amounting to -792.30%.

  • ProPhase Labs' EBT Margin fell 26454.00% to -792.30% in Q3 2025 from the same period last year, while for Sep 2025 it was -676.18%, marking a year-over-year decrease of 635369.00%. This contributed to the annual value of -622.50% for FY2024, which is 55851.00% down from last year.
  • Latest data reveals that ProPhase Labs reported EBT Margin of -792.30% as of Q3 2025, which was down 167.53% from -296.15% recorded in Q2 2025.
  • ProPhase Labs' 5-year EBT Margin high stood at 191.38% for Q4 2023, and its period low was -1,247.83% during Q4 2024.
  • Over the past 3 years, ProPhase Labs' median EBT Margin value was -326.90% (recorded in 2025), while the average stood at -361.24%.
  • Its EBT Margin has fluctuated over the past 5 years, first crashed by 143,922bps in 2024, then spiked by 21,914bps in 2025.
  • Over the past 5 years, ProPhase Labs' EBT Margin (Quarterly) stood at 21.31% in 2021, then plummeted by 4,508bps to -23.78% in 2022, then skyrocketed by 21,516bps to 191.38% in 2023, then slumped by 143,922bps to -1,247.83% in 2024, then tumbled by 26,454bps to -792.30% in 2025.
  • Its last three reported values are -792.30% in Q3 2025, -296.15% for Q2 2025, and -326.90% during Q1 2025.